Clinical Trial: Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT04822181) titled 'Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)' on March 26.

Brief Summary: Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries.

Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided by chance.

Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week.

The study will last for about 5 years. Participants will have up to 21 clinic visits and up to 9 pho...